21 / 164
FINANCIAL SITUATION
21
LISI 2015 FINANCIAL REPORT
2
/
ACTIVITY OF THE GROUP DURING THE FINANCIAL YEAR AND OUTLOOK
FOR THE COMING YEAR
2.1
/
LISI consolidated
At €1,458.1 million, consolidated sales revenue for the 2015
financial year was up +11.6% compared to 2014, and takes into
account the following positive elements:
■■
The contribution of Manoir Aerospace, consolidated as of June
5, 2014, amounted to €88 million, or 6.0% of consolidated
sales revenue, and 9.5% of LISI AEROSPACE revenue, which
now represents 64% of Group sales.
■■
The fall in the euro against most currencies and mainly the
dollar, generated a positive effect of €42 million.
■■
All the divisions gained overall market share with new
products.
Expressed at constant exchange rates and scope, the change
of -0.9% in sales revenue during the second half compared to
2014 masks a marked recovery during the last quarter: +1.2%,
compared to a high comparison base (+8.6% at the fourth
quarter of 2014) and after a third quarter notably marked by the
slowing in the automotive sector in China.
Organic growth continued to be positive in all divisions.
Comments regarding business of the fourth quarter
LISI
Consolidated
of which
LISI AEROSPACE
of which
LISI AUTOMOTIVE
of which
LISI MEDICAL
Q1
€381.6M
€240.4M
€122.8M
€18.6M
Q2
€374.2M
€236.9M
€118.3M
€19.2 M
Q3
€339.3M
€216.5M
€104.7M
€18.3M
Q4
€363.0M
€235.7M
€108.8M
€18.6M
2015
€
1,458.1M
€
929.6M
€
454.6M
€
74.8M
The fourth quarter was fairly dynamic in the three divisions,
with overall growth of +3.6%, of which +2.4% is due to currency
effects.
The Fasteners segment stood out in the LISI AEROSPACE
division, thanks to the implementation of new contracts
and positive activity in the USA. The Structural components
segment expects increased production to come of products
that are still in the industrialization phase.
The LISI AUTOMOTIVE division confirms its recovery after the
adjustment in the Chinese market which primarily affected
the third quarter. At +1.4%, the increase in sales revenue is
particularly significant in the Clipped solutions segment.
The LISI MEDICAL division marked a pause after strong growth
at the beginning of the year.